Pet Drug Reports

Bexagliflozin (Bexacat)adverse event reports that FDA received

Active ingredient

The name in brackets is a brand name with this active ingredient.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Read this first. FDA says this about the data:

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine publishes these words. Source: Adverse Event Reports for Animal Drugs and Devices, read on . The data have the reports that FDA received through .

This page is not veterinary advice. For an animal that is ill, speak to a veterinarian.

Contacting a veterinarianHow to report to FDA

From March 2023 to June 2026, FDA received 4,126 adverse event reports that name a drug with bexagliflozin as its active ingredient. Of the 4,126 reports, 4,053 (98.2%) are about cats.

In January to March 2026, FDA received 286 reports that name this drug. The signs that appear in the largest number of the 4,126 reports are "Ketosis", "Weight loss" and "Hyperglycaemia". A report is not proof that a drug caused a sign.

Reports that name this drug fell by 11.1% in the 12 months to June 2026, compared with the 12 months before. Reports for all animal drugs fell by 4.6% in the same periods. The newest months can get more reports in a later update. Reports about cats are 98.2% of the reports that name this drug, and 11% of all reports.

Since the last update of the FDA data

The site recorded an update of the FDA data on . FDA changed these counts for January to March 2026:

  • All species: from 257 to 286.
  • Cat: from 251 to 280.

January to March 2026 is the latest closed quarter in the data. In that quarter FDA received 286 reports that name bexagliflozin: 2 dog, 280 cat, 0 horse, 4 other or not given.

All updatesFeed of updates (RSS)

Signs that the reports list

A sign is a coded term from the report. The words in brackets are a plain gloss of the term. The percentage is the share of the 4,126 reports that list the sign. One report can list more than one sign.

The sign that is in the largest number of the reports comes first.

  1. Ketosis[ketones building up in the body]35.9%1,483 reports
  2. Weight loss26.4%1,091 reports
  3. Hyperglycaemia[high blood sugar]22.1%912 reports
  4. Diarrhoea[diarrhea]18.5%762 reports
  5. Lack of efficacy - NOS[the product did not have the expected effect]14.4%596 reports
  6. Lethargy[unusually tired or inactive]11.2%463 reports
  7. Vomiting11%452 reports
  8. Hypoglycaemia[low blood sugar]10.5%433 reports
  9. Glucosuria[sugar in the urine]9.8%405 reports
  10. Other abnormal test result NOS[abnormal laboratory result, type not specified]9.8%405 reports
  11. Not eating8.5%349 reports
  12. Diabetic ketoacidosis6.7%275 reports
  13. Elevated blood urea nitrogen (BUN)[a kidney value above the normal range]6.7%275 reports
  14. Weight gain6.2%256 reports
Show the next 16 signs
  1. Death by euthanasia[the animal was euthanized]6.1%252 reports
  2. Polyuria[passing more urine than usual]5.9%245 reports
  3. Dehydration5.9%243 reports
  4. Decreased appetite5.8%241 reports
  5. Elevated betahydroxybutyrate (BHBA)5.7%237 reports
  6. Polydipsia[drinking more than usual]5.2%214 reports
  7. Behavioural disorder NOS[behaviour change, type not specified]5%208 reports
  8. Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]5%208 reports
  9. Elevated creatinine[a kidney value above the normal range]4.2%174 reports
  10. Hypokalaemia[low blood potassium]3.9%160 reports
  11. Anorexia[not eating]3.7%152 reports
  12. Loose stool3.6%148 reports
  13. Elevated symmetrical dimethylarginine (SDMA)[a kidney value above the normal range]3.4%142 reports
  14. Elevated cholesterol (total)3.2%134 reports
  15. Ketonuria3.2%130 reports
  16. Urinary tract infection3.1%129 reports

The list shows 30 of 875 coded signs. A report is not proof that a drug caused a sign. Download all signs (CSV)

Reports by species

The share is of all 4,126 reports that name bexagliflozin. The other reports give a different species or no species.

Reports for each month, Jul 2021 to Jun 2026

Dog23 reports

No chart: no month has 5 or more reports.

Cat4,053 reports. Largest count in one month: 144 (Jan 2024)
Horse1 report

No chart: no month has 5 or more reports.

Other or not given49 reports. Largest count in one month: 5 (May 2024)

The month is the month in which FDA received the report. Each chart has its own scale. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

Reports by year

  • Dog
  • Cat
  • Horse
  • Other or not given
Reports that name bexagliflozin, by the year in which FDA received them and by species
YearDogCatHorseOther or not givenAll species
2026753317548
202531,2110181,232
2024111,4300181,459
2023287906887

2026 has the reports that FDA received through Jun 2026. Download the years (CSV)

What the reports record

Outcome at the time of the report

  • Recovered/Normal7.4%306
  • Recovered with Sequela[recovered, with a lasting effect]0%0
  • Ongoing41.9%1,728
  • Died1.7%69
  • Euthanized6%249
  • Outcome Unknown42%1,734

An outcome in a report is not proof that the drug caused it. The person who sends the report gives the outcome. Each share is of the 4,126 reports that name bexagliflozin.

A report about more than one animal can have more than one outcome.

Kind of report

  • Safety issue82.2%3,392
  • Lack of expected effectiveness3.9%162
  • Both safety and lack of expected effectiveness10.2%422
  • Manufacturing or product defect3.5%144
  • Other0.1%6

4,077 reports say if the event was serious. 21.7% of them have the serious flag. The person who sends the report sets the flag.

Show age, weight, breed and route

Age of the animal

  • Under 1 year0.1%5
  • 1 to 3 years1.3%54
  • 4 to 7 years11.9%489
  • 8 to 11 years37.1%1,531
  • 12 years and over37.7%1,555
  • Age not given11.9%492

Weight of the animal

  • Under 5 kg (11 lb)29.2%1,203
  • 5 to 9.9 kg (11 to 22 lb)49.2%2,031
  • 10 to 24.9 kg (22 to 55 lb)1%42
  • 25 to 44.9 kg (55 to 99 lb)0.2%7
  • 45 kg and over (99 lb and over)under 0.1%1
  • Weight not given20.4%842

Breed, where the report gives one breed

A breed with many animals has many reports.

Route in the report

  • Oral94.9%3,915
  • Topical0.2%9
  • Intrathoracicunder 0.1%2
  • Otherunder 0.1%2
  • Subcutaneousunder 0.1%2
  • Transdermalunder 0.1%1

Each bar is on a scale of 0 to 100%.

Approved animal drugs with this active ingredient (FDA Green Book)

This section is reference data. It has no report count.

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand.

Brand names

  • Bexacat

What the Green Book records give

Applications with an approval in force
1
Approved species
Cats
Dose forms
Tablet
Routes
Oral
Sale
RX (prescription)
Earliest approval date in the records

The species, dose forms and routes are the words of the Green Book records for all the applications together. One product can have fewer. The label of a product gives its approved use.

Applications in the Green Book of 2 Nov 2026, pioneer applications (NADA) first
Brand nameActive ingredientsSponsorApproved speciesApplication
BexacatBexagliflozinElanco US Inc.Not in the list of major speciesNADA 141-566

Next in the A to Z list

All drugs by active ingredient. Brand names A to Z

FDA pages for this drug

The site checked these addresses on . The links open in a new tab.

Cite this page

Pet Drug Reports. Bexagliflozin: adverse event reports that FDA received. https://petdrugreports.com/drug/bexagliflozin/ Source: FDA Center for Veterinary Medicine, openFDA Animal and Veterinary adverse event reports, export of . Reports received through .

Embed this card on your site

Copy this code into your page. The card shows the figures above with their source. A line under the card links to this page.

How embedding works. It is free. Keep the link in the card and the link line under it.

Where the data come from

The counts come from the openFDA Animal and Veterinary adverse event files, export of 30 Oct 2026. The files have the reports that the FDA Center for Veterinary Medicine received through 26 Jun 2026. The files mask brand and manufacturer names. The site counts a drug by the active ingredients that each record gives, and gives no count to a brand, an application or a company. Ingredient names and the lists of approved products follow the FDA Green Book of 2 Nov 2026. The site does not use the application number that a record has.

The site does not publish report text, lot numbers or details of a reporter. FDA's record is the authority. See how the site counts reports, the data sources and the corrections page.

Questions about these reports

Which brand are these reports about?

The openFDA records give the value "MSK" for the brand name and for the manufacturer name of each drug. FDA says that MSK means "masked". So the site cannot count a report for a brand. The Green Book section of this page lists the brand names with this active ingredient.

Do the reports show that the drug caused the signs?

No. FDA states this about the data.

When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event.

The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources.

FDA Center for Veterinary Medicine. Source: Adverse Event Reports for Animal Drugs and Devices

How many reports did FDA receive in the latest 12 months?

FDA received 1,153 reports in the 12 months to June 2026. It received 1,297 reports in the 12 months before. FDA says that a report can take 3 to 6 months to reach the public data. The newest months can get more reports in a later update.

What kinds of report are in the count?

Of the 4,126 reports received from March 2023 to June 2026, 82.2% are about a safety issue only. 14.2% are about a lack of expected effectiveness, alone or with a safety issue. 3.5% are about a defect of the product or its package.